Pfizer Launches US Bevacizumab At A 23% Discount
Zirabev Biosimilar Rival To Avastin Will Ship From Next Week
Pfizer is getting ready to ship its Zirabev biosimilar rival to Avastin in the US, at a price that represents a 23% discount to the brand and is also lower than the price for Amgen’s Mvasi biosimilar.
